Simonetta Viviani

She has devoted her professional career in the clinical management of patients with lymphomas and on the evaluation of new therapeutic strategies and new drugs. A field of her research interest included the study of late iatrogenic effects of cancer treatment and survivorship issues as well as the role of new serum biologic markers and genetic alterations in Hodgkin lymphoma. She served as principal investigator or sub-investigator in multiple national and international clinical trials. She is an active member of the Fondazione Italiana Linfomi and is involved in the Hodgkin Lymphoma Committee and in the Long-survivors Committee. She is a member of the American Society of Clinical Oncology since May 1989.